Applications: |
WB |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
SGK2 Positive Control for STJ502983 is synthetically produced from the sequence and is suitable for use in western blot applications. |
Formulation: |
Provided as 100 uL ready-to-use, in SDS-PAGE sample buffer (Laemelli's buffer) containing Tris, pH 6.8, 1 % SDS, Glycerol and Bromophenolblue blue as tracking dye. The sample is reduced by adding 2% beta mercaptoethanol. The protein concentration is |
Dilution Range: |
WB: 1:500 |
Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Gene Symbol: |
SGK2 |
Gene ID: |
10110 |
Uniprot ID: |
SGK2_HUMAN |
Specificity: |
This is positive control is recommended for use in combination with SGK2 antibody STJ502983. |
Tissue Specificity | Highly expressed in liver, kidney and pancreas, and at lower levels in brain. |
Post Translational Modifications | Activated by phosphorylation on Ser-356 by an unknown kinase (may be mTORC2 but not confirmed), transforming it into a substrate for PDPK1 which then phosphorylates it on Thr-193. |
Function | Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, survival and proliferation. Up-regulates Na(+) channels: SCNN1A/ENAC, K(+) channels: KCNA3/Kv1.3, KCNE1 and KCNQ1, amino acid transporter: SLC6A19, glutamate transporter: SLC1A6/EAAT4, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase. |
Peptide Name | Serine/Threonine-Protein Kinase Sgk2Serum/Glucocorticoid-Regulated Kinase 2 |
Database Links | Reactome: R-HSA-2672351 |
Cellular Localisation | CytoplasmNucleus |
Alternative Peptide Names | Serine/Threonine-Protein Kinase Sgk2 proteinSerum/Glucocorticoid-Regulated Kinase 2 proteinSGK2 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance